VERDICT
Venous thromboembolism in renally impaired patients and direct oral anticoagulants
Registration:
(Clinicaltrials.gov) NCT02664155
Sponsors:
Centre Hospitalier Universitaire de Saint Etienne
Saint Etienne, France
Status:
- Seeking sites and collaborators
Design
Winner of the 2018 INVENT International Collaboration Grant
RCT evaluating reduced doses of 2 DOACs (apixaban, rivaroxaban) compared to standard of care with heparins-vitamin K antagonists in patients with acute VTE and moderate or severe renal insufficiency
Participating Sites
Lead Network:
INNOVTE
Countries:
Canada, France, Serbia, Spain, Switzerland,Lead Investigators
Patrick Mismetti, MD
patrick.mismetti@chu-st-etienne.frSubscribe